These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Gottschall PE; Tatsuno I; Miyata A; Arimura A Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473 [TBL] [Abstract][Full Text] [Related]
3. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L; Ahrén B; Edgren G; Degerman E Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088 [TBL] [Abstract][Full Text] [Related]
4. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375 [TBL] [Abstract][Full Text] [Related]
5. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
6. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia. Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802 [TBL] [Abstract][Full Text] [Related]
7. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells. Bodart V; Babinski K; Ong H; De Léan A Endocrinology; 1997 Feb; 138(2):566-73. PubMed ID: 9002987 [TBL] [Abstract][Full Text] [Related]
9. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig. Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442 [TBL] [Abstract][Full Text] [Related]
10. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor. Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial properties of the pituitary adenylate cyclase-activating polypeptide: A new human antimicrobial peptide. Debbabi S; Groleau MC; Létourneau M; Narayanan C; Gosselin LL; Iddir M; Gagnon J; Doucet N; Déziel E; Chatenet D PLoS One; 2018; 13(11):e0207366. PubMed ID: 30462698 [TBL] [Abstract][Full Text] [Related]